Annovera offers long-lasting birth control

By Brian Buntz | July 21, 2021

In 2018, FDA indicated Annovera from TherapeuticsMD to prevent pregnancy.

A drug-device combination, Annovera combines a ring-shaped vaginal delivery system with hormones. The manufacturer designed the device to remain in place for three weeks followed by removal for one week. The product is effective for up to one year (or 13 menstrual cycles).

The manufacturer describes it as the only “long-lasting, reversible contraception that is procedure-free.”

The product is the brainchild of the non-profit research organization Population Council.

Filed Under: Drug Delivery
Tagged With: Annovera, birth control, TherapeuticsMD

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.